Patent ID: 8796276
Filing Date: 2014-08-05
Classification: A61K,A61P,C07D,C07F

Abstract:
1. A method of treating schizophrenia, mania, bipolar disorder, anxiety or depression by administering a compound of Formula III or its geometric isomers, enantiomers, diastereomers, racemates, pharmaceutically acceptable salts or solvates to a patient in need thereof: wherein A is selected from absent, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkenyl; R R R R R R D is selected from absent, —O—, —NR m and q are independently selected from 0, 1, and 2; p is 0, 1, 2, 3 or 4; r is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11; and, R Y and M are the same or different and each is a monovalent cation; or M and Y together is a divalent cation.